WILLIAM MCKEE
CIK 1237262 · Chief Financial Officer · last filed 2026-05-06
WILLIAM MCKEE is a Chief Financial Officer who has filed 46 SEC Form 4 insider transactions across 8 companies since 2007. The most recent filing, for ASRT, was dated May 6, 2026. Across all open-market trades the lifetime net is −$763.1K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $676.5K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$676.5K
8
46
-$763.1K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ASRT | Director | 27,936 | $23.48 | $655.9K | -$220.9K | 12 | 2026-05-06 |
| Rein Therapeutics, Inc. (ALRN) Delisted | Director | — | $2.11 | — | $0 | 4 | 2022-06-17 |
| CCCC | Chief Financial Officer | 5,263 | $3.90 | $20.5K | $100.0K | 1 | 2020-10-06 |
| AGILE THERAPEUTICS INC (AGRX) Delisted | Director | 17,949 | $1.51 | $27.1K | $0 | 5 | 2019-06-07 |
| Assertio Therapeutics, Inc (DEPO) Delisted | Director | — | — | — | $0 | 3 | 2018-05-10 |
| Dare Bioscience, Inc. (CERU) Delisted | Director | 3,418 | — | — | $0 | 4 | 2017-01-05 |
| AUXILIUM PHARMACEUTICALS INC (AUXL) Delisted | Director | 0 | — | — | -$642.2K | 9 | 2015-01-30 |
| BARR PHARMACEUTICALS INC (BRL) Delisted | EVP, CFO | 8,977 | — | — | $0 | 7 | 2008-12-19 |
Recent Filings
46 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-06 | ASRT | Grant (A) | +4,851 | $0 | EDGAR |
| 2025-05-09 | ASRT | Grant (A) | +53,750 | $0 | EDGAR |
| 2024-05-28 | ASRT | Grant (A) | +53,750 | $0 | EDGAR |
| 2023-08-15 | ASRT | Sell (S) | −22,000 | -$69.0K | EDGAR |
| 2023-05-12 | ASRT | Grant (A) | +31,194 | $0 | EDGAR |
| 2022-06-17 | Rein Therapeutics, Inc. (ALRN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-05-16 | ASRT | Sell (S) | −22,322 | -$52.5K | EDGAR |
| 2022-05-06 | ASRT | Grant (A) | +86,286 | $0 | EDGAR |
| 2021-06-17 | Rein Therapeutics, Inc. (ALRN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-05-13 | ASRT | Grant (A) | +357,143 | $0 | EDGAR |